BATS BZX Real-Time Price
As of 1:11pm ET
| +1.23 / +6.67%|
The 6 analysts offering 12-month price forecasts for PTC Therapeutics Inc have a median target of 22.50, with a high estimate of 28.00 and a low estimate of 15.00. The median estimate represents a +13.90% increase from the last price of 19.76.
The current consensus among 8 polled investment analysts is to Hold stock in PTC Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.